Clinical characteristics of patients who test positive for Clostridium difficile by repeat PCR

Daniel A Green1, Brie Stotler2, Dana Jackman3

  • 1Department of Pathology and Cell Biology, Columbia University College of Physicians and Surgeons, New York, New York, USA dag2149@columbia.edu.

Insights

Patients with a history of Clostridium difficile infection (CDI) are more likely to test positive on repeat PCR testing within seven days of a negative result. This suggests careful consideration for repeat testing in these individuals.

Area of Science:

  • Clinical Microbiology
  • Infectious Diseases
  • Diagnostic Assays

Background:

  • Polymerase Chain Reaction (PCR) assays offer high sensitivity for diagnosing Clostridium difficile infection (CDI).
  • Despite high sensitivity, a small percentage of patients test positive within seven days of a negative PCR result.
  • Understanding the characteristics of these patients is crucial for optimizing diagnostic strategies.

Purpose of the Study:

  • To evaluate the clinical characteristics of patients who test positive for CDI within seven days of a negative PCR test.
  • To determine if repeat PCR testing for CDI is appropriate in specific patient populations.

Main Methods:

  • Retrospective case-control study analyzing Xpert C. difficile PCR test results from May 2011 to September 2013.
  • Compared patients with positive repeat tests (within 7 days of a negative) to controls with negative repeat tests.
  • Statistical analysis included odds ratios and confidence intervals to identify risk factors.

Main Results:

  • 14,875 total PCR tests were performed, with 1,066 (7.2%) being repeat tests.
  • Eleven repeat tests (1.0%) were positive.
  • A history of prior CDI was the only independent risk factor associated with a positive repeat test (OR, 19.6; P < 0.001).

Conclusions:

  • Patients testing positive for C. difficile by PCR within seven days of a negative test are significantly more likely to have a prior CDI diagnosis.
  • This increased likelihood may stem from high relapse rates or empirical therapy leading to false negatives.
  • Findings support a more targeted approach to repeat CDI PCR testing based on patient history.